Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: A 6-month prospective pilot study

Eye

Volumn 19, Issue 8, 2005, Pages 885-890

  Lam, Dennis S C ^a   Chan, C K M ^a   Mohamed, S ^a   Lai, T Y Y ^a   Lee, V Y W ^a   Lai, W W ^a   Fan, D S P ^a   Chan, W M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cataract; Diabetic macular oedema; Intravitreal triamcinolone; Phacoemulsification

Indexed keywords

ANTIGLAUCOMA AGENT; APRACLONIDINE; TIMOLOL; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DOSE RESPONSE; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LENS IMPLANTATION; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; OPTICAL COHERENCE TOMOGRAPHY; PHACOEMULSIFICATION; PILOT STUDY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; RETINA MACULA EDEMA; RETINA MACULA LUTEA; SAFETY; THICKNESS; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 23944457629     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701686     Document Type: Article

References (28)

1. Gaudric A, Massin-Korobelnik P. Diabetic maculopathy: classification, epidemiology, spontaneous outcome, treatment. Diabetes Metab 1993; 19: 422-429.
2. Hamilton AMP, Ulbig MW, Polkinghorne P (eds). Epidemiology of diabetic retinopathy. In: Management of Diabetic Retinopathy. BMJ Publishing Group: London, 1996, pp 1-15.
3. Squirrell D, Bhola R, Bush J, Winder S, Talbot JF. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 2002; 86: 565-571.
4. Dowler JG, Kulwant SS, Hykin PG, Hamilton PA. The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 1999; 106: 663-668.
5. Dowler JF, Hykin PG, Hamilton PA. Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Ophthalmology 2000; 107: 457-462.
6. Antcliff RJ, Poulson A, Flanagan DW. Phacoemulsification in diabetics. Eye 1996; 10: 737-741.
7. The Royal College of Ophthalmologists. The Royal College of Ophthalmologists Published Guidelines: Cataract Surgery Guidelines 2001. http://www.rcophth.ac.uk/publications/index.html
8. Bresnick GH. Diabetic maculopathy: a critical review highlighting diffuse macular edema. Ophthalmology 1983; 90: 1301-1317.
9. Scholes GN, O'Brien WJ, Abrams GW, Kubicek MF. Clearance of triamcinolone from vitreous. Arch Ophthalmol 1985; 103: 1567-1569.
10. Wilson CA, Berkowita BA, Sato Y, Ando N, Handa JT, de Juan Jr E. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155-1159.
11. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001; 108: 765-772.
12. Stern AL, Tylor DM, Dalburg LA, Cosentino RT. Pseudophakic cystoid maculopathy: a study of 50 cases. Ophthalmology 1981; 88: 942-946.
13. Suckling RD, Maslin KF. Pseudophakic cystoid macular oedema and its treatment with local steroids. Aust NZ J Ophthalmol 1998; 16: 353-359.
14. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57-61.
15. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991; 98: 766-785.
16. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology 1991; 98: 1594-1602.
17. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-927.
18. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ J Ophthalmol 1999; 27: 431-432.
19. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24-27.
20. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 2003; 34: 386-390.
21. Sutter FK, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003; 87: 972-974.
22. Roth DB, Chieh J, Spirn MJ, Green SN, Yarian DL, Chaudhry NA. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003; 121: 1279-1282.
23. Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW. Endophthalmitis caused by Mycobacterium chelonae abscesses after intravitreal injection of triamcinolone. Arch Ophthalmol 2003; 121: 271-273.
24. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol 2002; 17: 167-180.
25. Pollack A, Leiba H, Bukelman A, Oliver M. Cystoid macular oedema following cataract extraction in patients with diabetes. Br J Ophthalmol 1992; 76: 221-224.
26. Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 2003; 121: 667-673.
27. Moshfeghi DM, Kaiser PK, Scott IU, Sears J, Benz M, Sinesterra JP et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136: 791-796.
28. Phillips II WB, Tasman WS. Postoperative endophthalmitis in association with diabetes mellitus. Ophthalmology 1994; 101: 508-518.